Anthony D'Amico

The World

Abiraterone shows promise in prostate cancer fight, Dimebon for Alzheimer’s

Environment

A 21-patient study has shown that the drug abiraterone can stop the testosterone that feeds prostate cancer. A larger international clinical trial is underway to test the drug before it can be deemed a ‘miracle drug. Also, Dimebon, once used as an antihistamine, has been found to improve cognitive abilities for Alzheimer’s patients.